Patient Square Capital LP — 13F holdings

Patient Square Capital LP reported 23 holdings worth $646M in its 13F filing for Q2 2026, filed August 12, 2026.

Largest positions

1. ROIV Roivant Sciences Ltd — $284M (44.0%)
2. RVMD REVOLUTION Medicines Inc — $51.7M (8.0%)
3. MIRM MIRUM PHARMACEUTICALS INC — $30.5M (4.7%)
4. ABVX ABIVAX SA — $27.5M (4.3%)
5. ONC BEONE MEDICINES LTD — $25.7M (4.0%)
6. PHVS PHARVARIS N V — $23.2M (3.6%)
7. ARGX ARGENX SE — $21.3M (3.3%)
8. UTHR UNITED THERAPEUTICS CORP DEL — $20.1M (3.1%)
9. BLTE BELITE BIO INC — $16.9M (2.6%)
10. COGT COGENT BIOSCIENCES INC — $16.4M (2.5%)